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Summary: Sodium dodecyl sulphate (SDS) electrophoresis of urinary proteins was used routinely for monitor-
ing more than 80 kidney transplant recipients äs out-patients during one year. Special attention was paid to
the question of whether this method can help the clinieian to differentiate between a graft rejection reaction
and Cyclosporin A-induced nephrotoxic damage. Two cases are presented showing the time course of
proteimiric patterns together with serum creatinine, total urinary protein and, in one case, the blood level
of Cyclosporin A. Changes of proteinuric patterns signalled the start of rejection and/or nephrotoxicity. A
homogeneous collective of 33 kidney recipients (first transplantation) with chronic glomerulonephritis äs a
basic disease was specially selected. In this collective, the distribution of proteinuric patterns among patients
and its dependence on immunosuppresive therapy was investigated. During the observation period of 7
months, two proteinuric patterns, "tubular" and "mixed weak", were found exclusively in Cyclosporin A-
treated patients. We ascribe this finding to nephrotoxic effect of Cyclosporin A. We found the SDS
electrophoresis of urinäry proteins to be a useful, non-invasive method for monitoring Cyclosporin A-treated
kidney transplant patients.
Überwachung von Harnproteinen mit SDS-Elektrophorese bei nierentransplantierten Patienten
Zusammenfassung: Die Natriumdodecylsulfat-(SDS-) Elektrophorese von Harnproteinen wird seit einem
Jahr zur routinemäßigen Überwachung von mehr als 80 ambulanten Nierentransplantierten angewendet.
Insbesondere sollte geklärt werden, ob diese Methode für den Kliniker eine Hilfe beim Erkennen und der
Differentiaidiagnose zwischen Cyclosporin -induzierter nephrotoxischer Einwirkung und Abstoßungsreak-
tion bietet. Es wurden zwei Fälle präsentiert, bei denen neben zeitlichen Änderungen des Proteinuriemusters
auch Verläufe von Kreatinin im Serum, Protein im Harn und, in einem Fall, Konzentration von Cyclosporin
A im Blut dargestellt sind. Änderungen im Verlauf des Proteinuriemusters signalisierten jeweils beginnende
Abstoßungsreaktionen bzw. nephrotoxische Einwirkungen von Cyclosporin A. Ein homogenes Kollektiv von
33 Nierentransplantierten (erste Transplantation) mit chronischer Glomerulonephritis als Basiserkrankung
wurde speziell ausgesucht. Es wurde in Abhängigkeit von immunsuppresiver Therapie die Verteilung des
jeweiligen Proteinuriemusters auf die einzelnen Patienten untersucht. In 7 Monaten Beobachtungszeit wurden
bei den Cyclosporin -behandelten Patienten exklusiv zwei Proteinuriemuster gefunden: „tubular" und
„gemischt—schwach". Wir schreiben diesen Befund der Cyclosporin -induzierten nephrotoxischen Einwir-
kung zu. Wir fanden die SDS-Elektrophorese von Harnproteinen als eine wertvolle Methode, die hilfreich
bei nicht-invasiver Überwachung von nierentransplantierten Patienten eingesetzt werden kann.
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Introduction
The immunosupressant "Cyclosporin A" (cyclospo-
rin) is widely used to prevent allograft rejection of
organ transplants (l, 2). However, in view of the
danger of serious side effects, it is necessary to mea-
sure the circulating levels of cyclosporin, in order to
adjust the dosage to the optimal level (3, 4). The
nephrotoxic side effect of cyclosporin is a most
dangerous complication in kidney transplantation
and therefore requires special attention (4—8). The
decision äs to whether graft rejection and/or nephro-
toxicity are responsible for the restriction of the func-
tionning of the transplanted kidney is a current clini-
cal problem (8). Sodium dodecyl sulphate (SDS) elec-
trophoresis of urinary proteins can be useful for the
detection of cyclosporin-induced nephrotoxicity. This
method provides Information about the distribution
of molecular weights of proteins in pathological ur-
ines. The molecular weight spectrum of urinary pro-
teins is, to a, large extent, indicative of the affected
part of the glomerulo-tubular apparatus of the kidney
(9, 10). High molecular weight proteins are assigned
to glomerular damage, low molecular weight proteins
to tubular damage. SDS electrophoresis permits con-
tinuous and non invasive monitoring, and is es-
pecially suitable for detecting and distinguishing be-
tween changes in proteinuric patterns, which indicate
the onset of damage due either to cyclosporin-in-
duced nephrotoxic damage, or to a rejection.
Materials and Methods
Patients
We have used SDS electrophoresis of urinary proteins routinely
over a period of one year for the weekly check up of kidney
graft recipients äs out patients of our nephrological unit. More
than 80 renal transplant patients havefbeen examined in this
way. From these, a homogeneous group was selected, who had
received only one transplant and whose original complaint had
been chronic glomerulonephritis (tab. l, top). Their urines were
analysed by SDS electrophoresis at l to 4 week intervals düring
7 months. Seventeen of these patients were treated with low
doses of steroids and cyclosporin and another 16 patients
recieved conventional immunosupressive therapy consisting of
azathiaprine and prednisolone.
Cyclosporin dosage
We started with a daily intravenous cyclosporin dose of 5 mg/
kg body weight, given continuously düring the first 3^-5 days
after surgery. This regimen was changed to an oral dose of 15
mg/kg body weight per day divided in 2 or 3 equal portioiis.
Depending on the cyclosporin concentrations in the blood the
daily cyclosporin dose was then reduced to a maintenance
dose of 5—8 mg/kg. The conventional therapy consisted of
azathioprine (2 mg/kg · day) and prednisolone (10 ml per day),
or an alternative schedule of 10 or 25 mg prednisolone every
second day. For controls, the findings of SDS-electrophoresis
were compared with the same kind of analysis of urines from
17 -transplanted patients, suffering from chronic glomeru-
lonephritits.
Samples and SDS electrophoresis
Four hour urine samples were collected under sterile conditions
and submitted on the same day to SDS electrophoresis or
Tab. 1. Patients with the basic renal disease, chronic glomerulonephritis.
Immunosuppressive therapy
Number of patients
Mean age (years)
Mean time after
transplantation (years)
Observation time
Transplant patients
corticosteroid + cyclosporin
17
44.9 ± 6.4
1.6 ±0.5
Transplant patients · ····
azathioprine -h prednisolone
16
46.9 ± 12.6
8.4 + 3.7
Non-transplant patients
none
17
44.1 ± 12.9
—
7 months in 1 to 4 weeks intervals
Distr ibution (n) of proteinuric patterns among patients
Proteinuric pattera
Physiological
Glomerular
selective
medium selective
non-selective
Tubular
Mixed
weak
medium
intensive
12
15
7
2
4
6
7
1
7
5
7
5
0
0.
3
5
4
5
4
1
0
0
1
i'7
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stored deep frozen (—20 °C) until analysed. Deep freezing did
not affect the result of the SDS electrophoresis. No preser-
vatives were added to samples and no concentration procedures
were necessary.
An adapted horizontal SDS electrophoresis was used permitting
simultaneous analysis of 22 samples s described elsewhere (11).
Results and Discussion
Using the SDS electrophoresis we were able to moni-
tor acute s well s chronic changes of kidney graft
function.
Evaluation of proteinuric pattern in the SDS electro-
phoresis
Table 2 shows a list of proteins found usually in pathological
urine samples with their molecular weights. These data, re-
ported in the literature (10, 12) were verified by our own
immunoblotting experiments. According to their pathophysiol-
ogical origin two groups of urinary proteins can be distinguish-
ed:
ι — glomerular proteins cornprising albumin and proteins with
l Mr > 67000
— tubular proteins with MT < 67000
Tab. 2 Urinary proteins
Glomerular proteins
180000
150000
130000
77000
67000
apolipoprotein A
immunoglobulin
polymeric albumin
transferrin
albumin
Mr Tubular proteins
54000
44000
40000
21000
15000
11800
ott-antitrypsin
cc2-acid glycoprotein
2-glycoprotein
retinol binding protein
lysozyme
2-microglobulin
We differentiated four main proteinuric patterns with some
subdivisions:
1. physiologlcal: total protein below 0.15 g/l
2. glomerular: containing only glomerular proteins subdivided
into
— selective (containing only albumin)
— medium selective (containing only albumin and transferrin)
— non selective (containing albumin, transferrin and immuno-
globulin)
3. tubular: containing albumin and proteins with MT < 67000,
with total protein > 0.15 g/l
4. mixed: proteinuric pattern, consisting of glomerular and
tubular; according total protein subdivided into:
— weak (0.15 to 0.3 g/l total protein)
— medium (0.3 to 1.0 g/l total protein)
— intensive (more than 1.0 g/l total protein)
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Case l
Figure l illustrates the time course of the pattern of
urinary proteins, serum creatinine and total urinary
protein of a 17 year old girl with diabetes type I. She
received a kidney graft and developed acute rejection
after 5 weeks (35 days). The proteinuric pattern
changed within this time from "glomerular unselec-
tive" to "mixed intensive". The change of proteinuric
pattern was accompanied by elevation of serum crea-
tinine (28th day), both observed 4 weeks before the
definitive increases of total urinary protein (39th day).
On the 43rd day the kidney graft was removed.
Case 2
In figure 2, the time course of the proteinuric pattern,
serum creatinine and cyclosporin blood levels can be
seen. A 35 year old man with chronic glomeru-
lonephritis received a kidney graft under treatment
with low doses of corticosteroids and cyclosporin.
In the 10th and 12Λ week after transplantation two
rejection episodes were observed, accompanied by a
change of proteinuric pattern towards "mixed inten-
sive". Later, after recovery after the 21st week, a
"tubular" proteinuric pattern was observed together
with a continuous elevation of serum creatinine (up
to 372 μπιοΐ/ΐ in the 27Λ week). Since the cyclosporin
blood level was near the suggested upper therapeutic
limit (3, 4) between the 24th and 27th week, we can
Interpret the occurrence of "tubular" proteinuria s
a cumulative transient toxic effect of cyclosporin on
tubular cells, s recently reported in patho-morpho-
logic studies (4, 5, 7).
Patients with chronic glomerulonephri t is s
a basic disease
Table l (bottom) indicates the results of SDS electro-
phoresis of urine samples during 7 months monitor-
ing. Comparing the number of patients, in which
different proteinuric patterns were found, we can see
that two types were found exclusively in patients
treated by low dose corticosteroids and cyclosporin:
- "tubular" (in 3 of 16 patients)
- "mixed weak" (in 8 of 16 patients)
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Fig. 1. All year old kidney transplant girl witb diabetes type I.
Time course of proteinuric pattern (top) together with
serum creatinine and total urinary protein (bottom).
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Fig. 2. A 35 year old man, with chronic glomerular nephritis
äs basic disease, receiviiig bis first kidney graft. Time
course of proteinuric pattern together with serum crea-
tinine total urinary protein and blood level of cyclospo-
rin.
The distribution of proteinuric types in patients
treated by conventional therapy (azathioprine and
prednisolone) is comparable to that of the control
group of non transplant patients with chronic glo-
merulonephritis; moreover, tubular and mixed weak
proteinuric types do not occur in these two groups.
The results agree with recently postulated nephro-
toxic effects of cyclosporine (7), where the tubule is
believed to be the primary site of an injury that is
initially reversible. Multiple injury of tubules then
leads to degeneration of entire nephrons.
This pathogenetic mechanism seems to correlate with
the SDS electrophoretic findings: tubular injury leads
to low molecular weight proteins in the urine. De-
generation of a few entire nephrons can be seen äs a
cause of "mixed weak" proteinuria. In conclusion we
can say that SDS electrophoresis of urinary proteins
provides useful, plausible and illustrative Information
for the clinician, especially with regard the changing
Status of patient. In addition, the method is non-
invasive.
Moreover, the diagnosis of tubular or glomerular
proteinuria by SDS electrophoresis can be based en-
tirely on the occurrence of a characteristic pattern of
urinary proteins. This can be seen äs a main advan-
tage in comparison with other methods, which mea-
sure a single parameter such äs urinary ß-2-microglo-
bulin or certain enzymes. The widely used measüre-
ment of ß-2-microglobulin äs a marker for tubular
damage is limited, because bf its instability in acid
urine samples (9). The measurement of enzymes in
urine is üseful for the diagnosis of tubular damage,
but this measurement is of low significance in the
differentiation between a rejection episode and cyclo-
sporin töxicity in renal transplant patients.
According to our studies, SDS electrophoresis is a
üseful accessory diagnostic method for differentiating
between kidney graft rejection and the nephrotoxic
side effect of cyclosporin A.
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